Record Information |
---|
Version | 1.0 |
---|
Creation date | 2015-10-09 22:28:34 UTC |
---|
Update date | 2017-01-19 02:36:13 UTC |
---|
FoodComEx ID | PC000114 |
---|
FoodDB Record | FDB013269 |
---|
Chemical Information |
---|
Name | Cholesterol |
---|
Description | Constituent either free or as esters, of fish liver oils, lard, dairy fats, egg yolk and bran
About 20?25% of total daily cholesterol production occurs in the liver; other sites of high synthesis rates include the intestines, adrenal glands and reproductive organs. Synthesis within the body starts with one molecule of acetyl CoA and one molecule of acetoacetyl-CoA, which are dehydrated to form 3-hydroxy-3-methylglutaryl CoA (HMG-CoA). This molecule is then reduced to mevalonate by the enzyme HMG-CoA reductase. This step is an irreversible step in cholesterol synthesis and is the site of action for the statins (HMG-CoA Reductase Inhibitors).; Cholesterol is a lipidic, waxy steroid found in the cell membranes and transported in the blood plasma of all animals. It is an essential component of mammalian cell membranes where it is required to establish proper membrane permeability and fluidity. In addition, cholesterol is an important precursor molecule for the biosynthesis of bile acids, steroid hormones, and several fat soluble vitamins. Cholesterol is the principal sterol synthesized by animals, but small quantities are synthesized in other eukaryotes, such as plants and fungi. It is almost completely absent among prokaryotes, which include bacteria.; Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The name originates from the Greek chole- (bile) and stereos (solid), and the chemical suffix -ol for an alcohol, as researchers first identified cholesterol (C27H45OH) in solid form in gallstones in 1784. Cholesterol is transported throughout the body via lipoprotein particles. The largest lipoproteins, which primarily transport fats from the intestinal mucosa to the liver, are called chylomicrons. They carry mostly triglyceride fats and cholesterol (that are from food and especially internal cholesterol secreted by the liver into the bile). In the liver, chylomicron particles give up triglycerides and some cholesterol, and are converted into low-density lipoprotein (LDL) particles, which carry triglycerides and cholesterol on to other body cells. In healthy individuals the LDL particles are large and relatively few in number. In contrast, large numbers of small LDL particles are strongly associated with promoting atheromatous disease within the arteries. (Lack of information on LDL particle number and size is one of the major problems of conventional lipid tests.). In conditions with elevated concentrations of oxidized LDL particles, especially small LDL particles, cholesterol promotes atheroma plaque deposits in the walls of arteries, a condition known as atherosclerosis, which is a major contributor to coronary heart disease and other forms of cardiovascular disease. (In contrast, HDL particles have been the only identified mechanism by which cholesterol can be removed from atheroma. Increased concentrations of large HDL particles, not total HDL particles, correlate with lower rates of atheroma progressions, even regression.). There is a world-wide trend to believe that lower total cholesterol levels tend to correlate with lower atherosclerosis event rates (though many studies refute this idea). Due to this reason, cholesterol has become a very large focus for scientific researchers trying to determine the proper amount of cholesterol needed in a healthy diet. However, the primary association of atherosclerosis with cholesterol has always been specifically with cholesterol transport patterns, not total cholesterol per se. For example, total cholesterol can be low, yet made up primarily of small LDL and small HDL particles and atheroma growth rates are high. In contrast, however, if LDL particle number is low (mostly large particles) and a large percentage of the HDL particles are large (HDL is actively reverse transporting cholesterol), then atheroma growth rates are usually low, even negative, for any given total cholesterol concentration. These effects are further complicated by the relative concentration of asymmetric dimethylarginin (ADMA) in the endothelium, since ADMA down-regulates production of nitric oxide, a relaxant of the endothelium. Thus, high levels of ADMA, associated with high oxidized levels of LDL pose a heightened risk factor for vascular disease. -- Wikipedia; Given the well-recognized role of cholesterol in cardiovascular disease, it is surprising that some studies have shown an inverse correlation between cholesterol levels and mortality in subjects over 50 years of age?an 11% increase overall and 14% increase in CVD mortality per 1 mg/dL per year drop in cholesterol levels. In the Framingham Heart Study, the researchers attributed this phenomenon to the fact that people with severe chronic diseases or cancer tend to have below-normal cholesterol levels. This explanation is not supported by the Vorarlberg Health Monitoring and Promotion Programme, in which men of all ages and women over 50 with very low cholesterol were increasingly likely to die of cancer, liver diseases, and mental diseases. This result indicates that the low cholesterol effect occurs even among younger respondents, contradicting the previous assessment among cohorts of older people that this is a proxy or marker for frailty occurring with age.; Mevalonate is then converted to 3-isopentenyl pyrophosphate in three reactions which require ATP. This molecule is decarboxylated to isopentenyl pyrophosphate, which is a key metabolite for various biological reactions. Three molecules of isopentenyl pyrophosphate condense to form farnesyl pyrophosphate through the action of geranyl transferase. Two molecules of farnesyl pyrophosphate then condense to form squalene by the action of squalene synthase in the endoplasmic reticulum. Oxidosqualene cyclase then cyclizes squalene to form lanosterol. Finally, lanosterol is then converted to cholesterol.; Within cells, cholesterol is the precursor molecule in several biochemical pathways. In the liver, cholesterol is converted to bile, which is then stored in the gallbladder. Bile contains bile salts, which solubilize fats in the digestive tract and aid in the intestinal absorption of fat molecules as well as the fat soluble vitamins, Vitamin A, Vitamin D, Vitamin E and Vitamin K. Cholesterol is an important precursor molecule for the synthesis of Vitamin D and the steroid hormones, including the adrenal gland hormones cortisol and aldosterone as well as the sex hormones progesterone, estrogens, and testosterone and their derivatives. |
---|
CAS Number | 57-88-5 |
---|
Structure | |
---|
Synonyms | Synonym | Source |
---|
(-)-cholesterol | biospider | (+)-ent-cholesterol | biospider | (20bFH)-cholest-5-en-3b-ol | biospider | (3β)-Cholest-5-en-3-ol | biospider | (3b)-cholest-5-en-3-ol | biospider | (3beta)-Cholest-5-en-3-ol | biospider | (3H)-Cholesterol | biospider | «delta»5-Cholesten-3-β-ol | biospider | 1zhy | biospider | 20-epi-cholesterol | biospider | 20-iso-cholesterol | biospider | 20bFH-cholest-5-en-3b-ol | biospider | 3-beta-Hydroxycholest-5-ene | biospider | 3β-Hydroxycholest-5-ene | biospider | 3beta-Hydroxy-5-cholestene | biospider | 3beta-Hydroxycholest-5-ene | biospider | 5-Cholesten-3β-ol | biospider | 5-Cholesten-3B-ol | biospider | 5-Cholesten-3beta-ol | biospider | 5, 6-Cholesten-3β-ol | biospider | 5,6-Cholesten-3β-ol | biospider | 5:6-Cholesten-3-ol | biospider | 5:6-Cholesten-3β-ol | biospider | 5:6-Cholesten-3beta-ol | biospider | Cholest-5-en-3-beta-ol | biospider | Cholest-5-en-3-ol | biospider | Cholest-5-en-3-ol (3β)- | biospider | Cholest-5-en-3-ol (3beta)- | biospider | Cholest-5-en-3-ol (3beta)-, labeled with tritium | biospider | Cholest-5-en-3-ol, (3β)- | biospider | Cholest-5-en-3-ol, (3beta)- | biospider | Cholest-5-en-3β-ol | biospider | cholest-5-en-3b-ol | biospider | cholest-5-en-3beta-ol | biospider | Cholesterin | db_source | Cholesterine | biospider | Cholesterinum | biospider | Cholesterinum Dps (D3-C1000) | biospider | Cholesterinum Dps 4ch-30ch | biospider | Cholesterinum-Injeel Forte Liq (6d,12d,30d,200d/1.1ml) | biospider | Cholesterol (JP15/NF) | biospider | Cholesterol (TN) | biospider | Cholesterol [usan:jan] | biospider | Cholesterol base h | biospider | Cholesterol, BAN, USAN | db_source | Cholesterolum | biospider | Cholesteryl alcohol | biospider | Cholestrin | biospider | Cholestrol | biospider | CLR | biospider | Cordulan | biospider | Dastar | biospider | delta(sup 5)-Cholesten-3-beta-ol | biospider | Delta5-Cholesten-3beta-ol | biospider | Dusoline | biospider | Dusoran | biospider | Dythol | biospider | Epicholesterin | biospider | Epicholesterol | biospider | Fancol CH | biospider | Hydrocerin | biospider | Kathro | biospider | Lanol | biospider | Lidinit | biospider | Lidinite | biospider | Liquid crystal CN/9 | biospider | Nimco cholesterol base h | biospider | Nimco cholesterol base No. 712 | biospider | NSC 8798 | db_source | Phospholipon & cholesterol | biospider | Provitamin d (van) | biospider | Soya phospholipon & Cholesterol (2:1 molar ratio) | biospider | Super hartolan | biospider | Synthechol(r) | biospider | SyntheChol(R) NS0 Supplement | biospider | Synthetic cholesterol | biospider | Tegolan | biospider | Tegolan (van) | biospider | Wool alcohols b. p | biospider | Wool alcohols b. p. | biospider |
|
---|
Chemical Formula | C27H46O |
---|
IUPAC name | 2,15-dimethyl-14-(6-methylheptan-2-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-ol |
---|
InChI Identifier | InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9,18-19,21-25,28H,6-8,10-17H2,1-5H3 |
---|
InChI Key | HVYWMOMLDIMFJA-UHFFFAOYSA-N |
---|
Isomeric SMILES | CC(C)CCCC(C)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C |
---|
Average Molecular Weight | 386.6535 |
---|
Monoisotopic Molecular Weight | 386.354866094 |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as cholesterols and derivatives. Cholesterols and derivatives are compounds containing a 3-hydroxylated cholestane core. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Cholestane steroids |
---|
Direct Parent | Cholesterols and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Cholesterol-skeleton
- Cholesterol
- Hydroxysteroid
- 3-hydroxysteroid
- 3-hydroxy-delta-5-steroid
- Delta-5-steroid
- Cyclic alcohol
- Secondary alcohol
- Organic oxygen compound
- Hydrocarbon derivative
- Organooxygen compound
- Alcohol
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Physico-Chemical Properties - Experimental |
---|
Property | Value | Reference |
---|
Experimental logP | Not Available | |
---|
Experimental Water Solubility | 9.5e-05 mg/mL at 30 oC | YALKOWSKY,SH & DANNENFELSER,RM (1992) |
---|
Melting Point | Mp 148.5° (anhyd.) | DFC |
---|
|
Foods of Origin |
---|
Food | Content Range | Average | Reference |
---|
Food | | | Reference |
---|
|
Production Data |
---|
Production Method | commercial |
---|
Production Method Reference | Not Available |
---|
Production Method Reference File | Not Available |
---|
Quantity Available | Production upon request, up to 6 g |
---|
Delivery Time | Not Available |
---|
Storage Form | solid |
---|
Storage Conditions | -80°C |
---|
Stability | Not Available |
---|
Purity | Not Available |
---|
Spectra |
---|
Spectral Data Upon Request | Not Available |
---|
Provider Information |
---|
|
Commercial Vendors |
---|
AKSci | C781 |
---|
AKSci | J91024 |
---|
BDH Chemicals | HMDB0000067 |
---|
Glentham | GE1295 |
---|
Glentham | GE7110 |
---|
Glentham | GE0100 |
---|
MetaSci | HMDB0000067 |
---|
Toronto Research Chemicals | C432501 |
---|